Turnstone Biologics (TSBX) Earnings Date & Reports

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TSBX is expected to report earnings to rise 21.43% to -68 cents per share on May 19

Turnstone Biologics TSBX Stock Earnings Reports

Q1'25

Est.

$-0.68

Q4'24

Beat

by $0.20

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.15

Q1'24

Missed

by $0.08

The last earnings report on March 29 showed earnings per share of -56 cents, beating the estimate of -75 cents. With 119.65K shares outstanding, the current market capitalization sits at 7.38M.

View a ticker or compare two or three

Compare

TSBX